Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin-Myocardial Infarction Study
NCT00000491Phase 3Completed
- Sponsor
- National Heart, Lung, and Blood Institute
- Start
- Oct 1974
- Modality
- Orthosteric Ligands
01
Overview
Phase 3, randomised, double-blind trial in myocardial infarction (MI) comparing Aspirin with Placebo (2 arms). Primary endpoint: Total Mortality at 3 years. Started Oct 1974; status: completed.
02
Drugs
aspirin
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on NCT00000491.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000491.